Forsta AP Fonden decreased its position in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 17.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 11,900 shares of the company's stock after selling 2,500 shares during the quarter. Forsta AP Fonden's holdings in Molina Healthcare were worth $4,100,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently made changes to their positions in MOH. Quent Capital LLC increased its holdings in shares of Molina Healthcare by 6.8% in the 1st quarter. Quent Capital LLC now owns 489 shares of the company's stock valued at $201,000 after acquiring an additional 31 shares during the period. Custom Index Systems LLC lifted its position in shares of Molina Healthcare by 5.0% during the second quarter. Custom Index Systems LLC now owns 690 shares of the company's stock valued at $205,000 after buying an additional 33 shares during the last quarter. AlphaMark Advisors LLC boosted its holdings in shares of Molina Healthcare by 1.1% in the 2nd quarter. AlphaMark Advisors LLC now owns 3,543 shares of the company's stock valued at $1,053,000 after buying an additional 40 shares in the last quarter. Oliver Luxxe Assets LLC grew its position in shares of Molina Healthcare by 1.3% in the 3rd quarter. Oliver Luxxe Assets LLC now owns 4,428 shares of the company's stock worth $1,526,000 after buying an additional 55 shares during the last quarter. Finally, Arizona State Retirement System raised its stake in shares of Molina Healthcare by 0.4% during the 2nd quarter. Arizona State Retirement System now owns 16,092 shares of the company's stock worth $4,784,000 after acquiring an additional 57 shares in the last quarter. 98.50% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
A number of equities analysts have recently issued reports on MOH shares. StockNews.com raised Molina Healthcare from a "hold" rating to a "buy" rating in a research report on Friday, October 18th. Jefferies Financial Group decreased their price target on Molina Healthcare from $354.00 to $297.00 and set a "hold" rating for the company in a research note on Wednesday, July 24th. Stephens restated an "equal weight" rating and set a $320.00 price target on shares of Molina Healthcare in a research note on Thursday, July 25th. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of Molina Healthcare from $354.00 to $353.00 and set a "hold" rating for the company in a research report on Monday, July 29th. Finally, Cantor Fitzgerald reiterated an "overweight" rating and issued a $406.00 target price on shares of Molina Healthcare in a research note on Thursday, October 24th. One research analyst has rated the stock with a sell rating, six have given a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, Molina Healthcare presently has a consensus rating of "Moderate Buy" and a consensus target price of $367.00.
View Our Latest Research Report on Molina Healthcare
Molina Healthcare Stock Performance
MOH traded up $0.18 during midday trading on Wednesday, hitting $323.31. 230,625 shares of the company were exchanged, compared to its average volume of 527,390. Molina Healthcare, Inc. has a 1-year low of $272.69 and a 1-year high of $423.92. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 0.49. The firm has a market capitalization of $18.95 billion, a price-to-earnings ratio of 17.77, a price-to-earnings-growth ratio of 0.99 and a beta of 0.58. The company's 50 day simple moving average is $334.11 and its 200 day simple moving average is $328.58.
Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings results on Wednesday, October 23rd. The company reported $6.01 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $5.96 by $0.05. The company had revenue of $10.34 billion during the quarter, compared to the consensus estimate of $9.92 billion. Molina Healthcare had a return on equity of 28.09% and a net margin of 2.84%. Molina Healthcare's revenue for the quarter was up 21.0% on a year-over-year basis. During the same period in the previous year, the company posted $5.05 earnings per share. As a group, sell-side analysts predict that Molina Healthcare, Inc. will post 23.5 earnings per share for the current year.
Insider Activity at Molina Healthcare
In other news, CAO Maurice Hebert sold 393 shares of the stock in a transaction dated Thursday, August 15th. The shares were sold at an average price of $346.52, for a total transaction of $136,182.36. Following the sale, the chief accounting officer now directly owns 9,473 shares of the company's stock, valued at $3,282,583.96. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 1.10% of the stock is owned by company insiders.
Molina Healthcare Company Profile
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
See Also
Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for November 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.